Primary Site >> Esophagus Cancer
Gene >> SOX2
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|
|
Ref: Comparative genomics on mammalian Fgf3-Fgf4 locus. PMID: 15942670 |
Ref: Isolation and identification of cancer stem-like cells in esophageal carcinoma cell lines. PMID: 18680391 Ref: Oct3/4 and Sox2 are significantly associated with an unfavorable clinical outcome in human esophageal squamous cell carcinoma. PMID: 19414369 |
Ref: SOX2 gene amplification and protein overexpression are associated with better outcome in squamous cell lung cancer. PMID: 21460799 |
Ref: Increased Levels of Circulating and Tissue mRNAs of Oct-4, Sox-2, Bmi-1 and Nanog is ESCC Patients: Potential Tool for Minimally Invasive Cancer Diagnosis. PMID: 22493560 Ref: Immunohistochemical panel for distinguishing esophageal adenocarcinoma from squamous cell carcinoma: a combination of p63, cytokeratin 5/6, MUC5AC, and anterior gradient homolog 2 allows optimal subtyping. PMID: 22748473 Ref: Expression analysis of iPS cell - inductive genes in esophageal squamous cell carcinoma by tissue microarray. PMID: 23225459 |
Ref: The usefulness of three-dimensional cell culture in induction of cancer stem cells from esophageal squamous cell carcinoma cell lines. PMID: 23602898 Ref: Physiological beta-catenin signaling controls self-renewal networks and generation of stem-like cells from nasopharyngeal carcinoma. PMID: 24073846 |
Ref: Forthcoming prognostic markers for esophageal cancer: a systematic review and meta-analysis. PMID: 24490044 Ref: miR-625 down-regulation promotes proliferation and invasion in esophageal cancer by targeting Sox2. PMID: 24508466 Ref: Loss of CD44 and SOX2 expression is correlated with a poor prognosis in esophageal adenocarcinoma patients. PMID: 24833101 |
Ref: Bardoxolone methyl induces apoptosis and autophagy and inhibits epithelial-to-mesenchymal transition and stemness in esophageal squamous cancer cells. PMID: 25733817 Ref: Evaluating the miR-302b and miR-145 expression in formalin-fixed paraffin-embedded samples of esophageal squamous cell carcinoma. PMID: 25773691 Ref: Silencing SOX2 Expression by RNA Interference Inhibits Proliferation, Invasion and Metastasis, and Induces Apoptosis through MAP4K4/JNK Signaling Pathway in Human Laryngeal Cancer TU212 Cells. PMID: 26001828 Ref: Transforming growth factor-beta1 promotes the migration and invasion of sphere-forming stem-like cell subpopulations in esophageal cancer. PMID: 26096658 Ref: Comprehensive Genomic Profiling of Advanced Esophageal Squamous Cell Carcinomas and Esophageal Adenocarcinomas Reveals Similarities and Differences. PMID: 26336083 Ref: CD44, SHH and SOX2 as novel biomarkers in esophageal cancer patients treated with neoadjuvant chemoradiotherapy. PMID: 26364884 |
Ref: Prognostic value of Sox2 expression in digestive tract cancers: A meta-analysis. PMID: 27376796 |
Ref: SIX1 maintains tumor basal cells via transforming growth factor-beta pathway and associates with poor prognosis in esophageal cancer. PMID: 27987372 Ref: Increased Numb protein expression predicts poor clinical outcomes in esophageal squamous cell carcinoma patients. PMID: 28095111 Ref: Genetic Alterations in Esophageal Tissues From Squamous Dysplasia to Carcinoma. PMID: 28365443 Ref: SOX2-silenced squamous cell carcinoma: a highly malignant form of esophageal cancer with SOX2 promoter hypermethylation. PMID: 28862264 Ref: Mutation landscape and intra-tumor heterogeneity of two MANECs of the esophagus revealed by multi-region sequencing. PMID: 29050228 Ref: The management of localized esophageal squamous cell carcinoma: Western approach. PMID: 29129086 |